3 completed. 3 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Joakim Dillner: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Convalescent Plasma for Treatment of COVID-19 SARS-CoV-2 convalescent plasma, Standard of care - Covid19 | Phase 2 / Phase 3 | Completed | Joakim Dillner | 59 | 2020-12-03 | 2022-02-09 |
| Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study SARS-CoV-2 convalescent plasma - COVID-19 | Phase 1 / Phase 2 | Completed | Joakim Dillner | 10 | 2020-05-07 | 2021-12-03 |
| Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) SARS-CoV-2 convalescent plasma - COVID-19 | Phase 1 / Phase 2 | Completed | Joakim Dillner | 10 | 2020-04-10 | 2021-12-16 |
COVID-19 Serotherapy (3) · Standard of Care (1)
Sweden (3)